Hip fracture patients have more vertebral deformities than subjects in population-based studies

Bone

Volumn 32, Issue 2, 2003, Pages 180-184

  Hasserius, R ^a   Johnell, O ^a   Nilsson, B E ^a   Thorngren, K G ^a   Jonsson, K ^a   Mellstrom D ^b   Redlund Johnell, I ^a   Karlsson, M K ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Vasa Hospital   (Sweden)

Author keywords

Hip fracture; Lateral spine radiographs; Morphometry; Osteoporosis; Predictive value; Vertebral deformity

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FEMUR PERTROCHANTERIC FRACTURE; FEMUR SUBTROCHANTERIC FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; VERTEBRA MALFORMATION;

EID: 0037291327     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(02)00951-1     Document Type: Article

References (29)

1. Browner W.S., Pressman A.R., Nevitt M.C., Cummings S.R. Mortality following fractures in older women. The study of osteoporotic fractures. Arch Intern Med. 156:1996;1521-1525.
2. Center J.R., Nguyen T.V., Schneider D., Sambrook P.N., Eisman J.A. Mortality after all major types of osteoporotic fracture in men and women an observational study . Lancet. 353:1999;878-882.
3. Sernbo I., Johnell O. Consequences of a hip fracture a prospective study over 1 year . Osteoporosis Int. 3:1993;148-153.
4. Black D.M., Arden N.K., Palermo L., Pearson J., Cummings S.R. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. J Bone Miner Res. 14:1999;821-828.
5. Fujiwara S., Kasagi F., Yamada M., Kodama K. Risk factors for hip fracture in a Japanese cohort. J Bone Miner Res. 12:1997;998-1004.
6. Ismail A.A., Cockerill W., Cooper C., Finn J.D., Abendroth K., Parisi G., et al. Prevalent vertebral deformity predicts incident hip though not distal forearm fracture results from the European Prospective Osteoporosis Study . Osteoporos Int. 12:2001;85-90.
7. Cummings S.R., Nevitt M.C., Browner W.S., Stone K., Fox K.M., et al. Risk factors for hip fractures in white women. N Engl J Med. 332:1995;767-773.
8. Gardsell P., Johnell O., Nilsson B.E., Nilsson J.A. The predictive value of fracture, disease, and falling tendency for fragility fractures in women. Calcif Tissue Int. 45:1989;327-330.
9. Gunnes M., Mellström D., Johnell O. How well can a previous fracture indicate a new fracture? A questionnaire study of 29,802 postmenopausal women. Acta Orthop Scand. 69:1998;508-512.
10. Johnell O., Oden A., Caulin F., Kanis J.A. Acute and long-term increase in fracture risk after hospitalization for vertebral fracture. Osteoporos Int. 12:2001;207-214.
11. Kotowicz M.A., Melton L.J. III, Cooper C., Atkinson E.J., O'Fallon W.M., et al. Risk of hip fracture in women with vertebral fracture. J Bone Miner Res. 9:1994;599-605.
12. Melton L.J. III, Atkinson E.J., Cooper C., O'Fallon W.M., Riggs B.L. Vertebral fractures predict subsequent fractures. Osteoporos Int. 10:1999;214-221.
13. Mannius S., Mellström D., Lindstedt G., Rundgren Å, Zetterberg C. Health statusand risk for hip fracture a case control study of 70-75-year-olds . Arch Gerontol Geriatr. 15:1992;151-162.
14. Orwoll E., Ettinger M., Weiss S., Miller P., Kendler D., Graham J., et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med. 343:2000;604-610.
15. Black D.M., Cummings S.R., Karpf D.B., Cauley J.A., Thompson D.E., et al. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet. 348:1996;1535-1541.
16. Harris S.T., Watts N.B., Genant H.K., McKeever C.D., Hangartner T., Keller M., et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group . J Am Med Assoc. 282:1999;1344-1352.
17. Lufkin E.G., Wahner H.W., O'Fallon W.M., Hodgson S.F., Kotowicz M.A., Lane A.W., et al. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med. 117:1992;1-9.
18. McClung M.R., Geusens P., Miller P.D., Zippel H., Bensen W.G., et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med. 344:2001;333-340.
19. Uitewaal P.J.M., Lips P., Netelenbos J.C. An analysis of bone structure in patients with hip fracture. Bone Miner. 3:1987;63-73.
20. Hasserius R., Redlund-Johnell I., Mellström D., Johansson C., Nilsson B.E., et al. Vertebral deformation in urban Swedish men and women. Prevalence based on 797 subjects. Acta Orthop Scand. 72:2001;273-278.
21. O'Neill T.W., Felsenberg D., Varlow J., Cooper C., Kanis J.A., et al. The prevalence of vertebral deformity in European men and women The European Vertebral Osteoporosis Study . J Bone Miner Res. 11:1996;1010-1018.
22. Johansson C., Mellström D., Rosengren K., Rundgren Å. Prevalence of vertebral fractures in 85-year-olds. Acta Orthop Scand. 64:1993;25-27.
23. Assessing vertebral fractures. J Bone Miner Res. 10:1995;518-523.
24. Nilsson B.E. Spinal osteoporosis and femoral neck fracture. Clin Orthop. 68:1970;93-95.
25. Lips P., Taconis W.K., van Ginkel F.C., Netelenbos J.C. Radiologic morphometry in patients with femoral neck fractures and elderly control subjects. Clin Orthop. 183:1984;64-70.
26. Hutchinson TA, Polansky SM, Feinstein AR. Post-menopausal œstrogens protect against fractures of hip and distal radius. Lancet Oct 1979; 705-9.
27. Lunt M., Felsenberg D., Reeve J., Benevolenskaya L., Cannata J., et al. Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers. The EVOS study. J Bone Miner Res. 12:1997;1883-1894.
28. Marshall D., Johnell O., Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J. 312:1996;1254-1259.
29. Ross P.D., Davis J.W., Epstein R.S., Wasnich R.D. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 114:1991;919-923.